The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension

[1]  N. Rogers,et al.  HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction , 2015, Cardiovascular research.

[2]  David D. Roberts,et al.  Thrombospondin-1 Signaling through CD47 Inhibits Self-renewal by Regulating c-Myc and Other Stem Cell Transcription Factors , 2013, Scientific Reports.

[3]  R. Kaiser,et al.  Decreased TSP-1 following percutaneous coronary intervention is associated with major adverse cardiac events in ST-elevation myocardial infarction. , 2013, Clinical hemorheology and microcirculation.

[4]  N. Rogers,et al.  Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1. , 2012, Cardiovascular research.

[5]  D. Roberts,et al.  Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. , 2011, Pharmacological research.

[6]  D. Roberts,et al.  Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. , 2010, Cardiovascular research.

[7]  D. Roberts,et al.  Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling by Disrupting Its Association with CD47* , 2010, The Journal of Biological Chemistry.

[8]  C. Hales,et al.  Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension , 2010, Journal of cardiothoracic surgery.

[9]  D. Roberts,et al.  Thrombospondin‐1 is an inhibitor of pharmacological activation of soluble guanylate cyclase , 2010, British journal of pharmacology.

[10]  K. Wittkowski,et al.  In Vitro and In Vivo Evidence that Thrombospondin-1 (TSP-1) Contributes to Stirring- and Shear-Dependent Activation of Platelet-Derived TGF-β1 , 2009, PloS one.

[11]  M. Gladwin,et al.  Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation. , 2009, Nitric oxide : biology and chemistry.

[12]  S. Germain,et al.  Modulation of Macrophage Activation State Protects Tissue from Necrosis during Critical Limb Ischemia in Thrombospondin-1-Deficient Mice , 2008, PloS one.

[13]  D. Wink,et al.  Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. , 2008, The American journal of pathology.

[14]  J. Bernal,et al.  A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. , 2007, The American journal of pathology.

[15]  Julia Fukuyama,et al.  Thrombospondin-1 Inhibits Nitric Oxide Signaling via CD36 by Inhibiting Myristic Acid Uptake* , 2007, Journal of Biological Chemistry.

[16]  A. Pries,et al.  Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo. , 2006, International journal of immunopathology and pharmacology.

[17]  Y. Shiratori,et al.  Thrombospondin-1 is Induced in Rat Myocardial Infarction and Its Induction is Accelerated by Ischemia/Reperfusion , 2005, Experimental biology and medicine.

[18]  J. Lawler,et al.  Antiangiogenic Treatment with Three Thrombospondin-1 Type 1 Repeats versus Gemcitabine in an Orthotopic Human Pancreatic Cancer Model , 2005, Clinical Cancer Research.

[19]  M. Entman,et al.  Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts , 2005, Circulation.

[20]  A. Giaccia,et al.  Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  L. Forman,et al.  Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. , 1998, The Journal of laboratory and clinical medicine.

[22]  S. Kobayashi,et al.  The molecular biologic study of the expression of thrombospondin in vascular smooth muscle cells and mesangial cells. , 1991, The Journal of diabetic complications.

[23]  E. Jaffe,et al.  Monocytes and macrophages synthesize and secrete thrombospondin. , 1985, Blood.

[24]  E. Jaffe,et al.  Synthesis and secretion of thrombospondin by cultured human endothelial cells , 1982, The Journal of cell biology.